Pronounce: ee-FLOR-ni-theen
Classification: Kinase Inhibitor
Eflornithine is a type of targeted therapy called a kinase inhibitor. A kinase is an enzyme that promotes cell growth. There are many types of kinases, which control different phases of cell growth. By blocking a particular enzyme from working, this medication can slow the growth of cancer cells. This medication is an ornithine decarboxylase inhibitor. This means that it blocks polyamines which allow cells to grow.
This medication comes in a tablet form. It is often taken twice a day and your dose will depend on the size of your body. It can be taken with or without food and can be taken whole, chewed, or crushed. If you crush the medication, you should add it to 2 tablespoons of soft food or liquid. Any tablets that are crushed should be taken or thrown away after one hour. You may need to rinse your mouth with water and swallow to make sure you take all of the medication.
It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed.
If you miss a dose of this medication, you should take it again as soon as possible. If your next dose is 7 hours away or less, skip the missed dose and take your next dose as scheduled. If you vomit after taking Eflornithine, you should not take an additional dose.
Before starting this medication, your provider will ask you to complete a baseline audiogram (hearing test) and blood tests to check your liver and blood count. This will help to monitor if you are having side effects from the medication.
Store your medication in the original, labeled container at room temperature and in a dry location (unless otherwise directed by your healthcare provider or pharmacist). Keep containers out of reach of children and pets.
Eflornithine is available through select specialty and retail pharmacies. Your oncology team will work with your prescription drug plan to identify an in-network pharmacy for the distribution of this medication.
This medication may be covered under your prescription drug plan. Patient assistance may be available to qualifying individuals without prescription drug coverage. Co-pay cards, which reduce the patient co-pay responsibility for eligible commercially (non-government sponsored) insured patients, may also be available. Your care team can help you find these resources if they are available.
There are a number of things you can do to manage the side effects of eflornithine. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Eflornithine can cause ear issues like infections and inflammation. Ear infections and inflammation can lead to hearing loss. Your provider will check your hearing before, during, and after taking this medication. Let your provider know if you have pain in your ears or notice any hearing changes.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary while taking this medication and for at least one week after the last dose. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while taking this medication and for at least one week after the last dose.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania